Cocrystal Pharma, Inc. Common Stock (COCP) is a publicly traded Healthcare sector company. As of July 17, 2026, COCP trades at $0.96 with a market cap of $13.24M and a P/E ratio of -1.33. COCP moved +0.00% today. Year to date, COCP is -2.95%; over the trailing twelve months it is -43.11%. Its 52-week range spans $0.86 to $3.26. Analyst consensus is buy with an average price target of $10.00. Rallies surfaces COCP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for COCP, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $0.96 |
| Market Cap | $13.24M |
| P/E Ratio | -1.33 |
| EPS | $-0.73 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.26 |
| 52-Week Low | $0.86 |
| Volume | 3.25K |
| Avg Volume | 0 |
| Revenue (TTM) | $225.00K |
| Net Income | $-8.83M |
| Gross Margin | 0.00% |
1 analysts cover COCP: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.00.